Article
The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.
Antimicrobial agents and chemotherapy - 1 May 2008
Garvey Mark I, Piddock Laura J V
Abstract excerpt
One way to combat multidrug-resistant microorganisms is the use of efflux pump inhibitors (EPIs). Spontaneous mutants resistant to the EPI reserpine selected from Streptococcus pneumoniae NCTC 7465 and R6 at a frequency suggestive of a single mutational event were also multidrug resistant. No mutations in pmrA (which encodes the efflux protein PmrA) were detected, and the expression of pmrA was unaltered in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
